Cervical smear test death provokes review:
This article was originally published in Clinica
Executive Summary
An independent review of cervical smear testing at the Kent and Canterbury Hospital has been ordered by a UK health minister, Baroness Jay. The hospital admitted that a woman died of the disease after hospital staff failed to notice she had cancer from a smear test. Both the chairman and chief executive of the trust have resigned. Five other women have died of cancer after smear tests at the hospital; 47 other women were found to be clear in tests, but have since been treated for the disease.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.